{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:03:46Z","timestamp":1768680226168,"version":"3.49.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les Hepatites Virales","doi-asserted-by":"publisher","award":["No 33\/CCS6\/AO 2013-1"],"award-info":[{"award-number":["No 33\/CCS6\/AO 2013-1"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les Hepatites Virales","doi-asserted-by":"publisher","award":["No ANRS 12 312 PreCASA"],"award-info":[{"award-number":["No ANRS 12 312 PreCASA"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.00409","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T12:23:47Z","timestamp":1520943827000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Na\u00efve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test"],"prefix":"10.3389","volume":"9","author":[{"given":"Elvis","family":"Temfack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Kouanfack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonella","family":"Mossiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Loyse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie C.","family":"Fonkoua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edle F.","family":"Molloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinata","family":"Koulla-Shiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Delaporte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Dromer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"key":"B1","year":"2013","journal-title":"A Phase III, Randomised, Controlled Trial for the Treatment of HIV-Associated Cryptococcal Meningitis: Oral Fluconazole Plus Flucytosine or One Week Amphotericin B-Based Therapy vs Two Weeks Amphotericin B-based Therapy"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005304","article-title":"Preheating of urine improves the specificity of urinary cryptococcal antigen testing using the lateral flow assay.","volume":"11","author":"Brito-Santos","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004773.pub2","article-title":"Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV.","volume":"20","author":"Chang","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00002030-200402200-00024","article-title":"Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras.","volume":"18","author":"Dromer","year":"2004","journal-title":"AIDS"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","article-title":"Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.","volume":"16","author":"French","year":"2002","journal-title":"AIDS"},{"key":"B6","year":"2015","journal-title":"Activite de Lutte Contre le VIH\/SIDA et Les IST au Cameroun: Rapport Annuel 2015"},{"key":"B7","year":"2017","journal-title":"CrAg LFA Norman, Oklahoma, USA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/cid\/civ939","article-title":"Editorial commentary: cryptococcosis in AIDS: new data but questions remain.","volume":"62","author":"Jackson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/1545109712459077","article-title":"Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation.","volume":"11","author":"Jarvis","year":"2012","journal-title":"J. Int. Assoc. Physicians AIDS Care (Chic)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069288","article-title":"Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa.","volume":"8","author":"Jarvis","year":"2013","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1086\/597262","article-title":"Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.","volume":"48","author":"Jarvis","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1097\/QAD.0000000000000872","article-title":"Six-month outcomes of HIV-infected patients given short-course fluconazole therapy for asymptomatic cryptococcal antigenemia.","volume":"29","author":"Kapoor","year":"2015","journal-title":"AIDS"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","article-title":"Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.","volume":"22","author":"Lawn","year":"2008","journal-title":"AIDS"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv046","article-title":"Cryptococcal antigenemia in immunocompromised human immunodeficiency virus patients in rural Tanzania: a preventable cause of early mortality.","volume":"2","author":"Letang","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/j.1365-3156.2007.01874.x","article-title":"Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.","volume":"12","author":"Liechty","year":"2007","journal-title":"Trop. Med. Int. Health"},{"key":"B16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/cid\/civ936","article-title":"Cryptococcal antigen screening in patients initiating ART in South Africa: a prospective cohort study.","volume":"62","author":"Longley","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells\/microL who start HIV therapy in resource-limited settings.","volume":"51","author":"Meya","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.","volume":"385","author":"Mfinanga","year":"2015","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/QAI.0b013e31811ed32c","article-title":"Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.","volume":"45","author":"Micol","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013856","article-title":"Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia.","volume":"5","author":"Micol","year":"2010","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1086\/368091","article-title":"The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.","volume":"36","author":"Mirza","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"B22","article-title":"\u201cPre-art cryptococcal antigen titer associated with preemptive fluconazole failure,\u201d in","author":"Morawski","year":"2016","journal-title":"Proceedings of the Conference on Retroviruses and Opportunistic Infections"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1097\/QAI.0000000000000527","article-title":"Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia.","volume":"68","author":"Pac","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S1473-3099(11)70245-6","article-title":"Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial.","volume":"11","author":"Parkes-Ratanshi","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(15)60455-X","article-title":"HIV care: ART adherence support and cryptococcal screening.","volume":"385","author":"Rajasingham","year":"2015","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1097\/QAI.0b013e31824c837e","article-title":"Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care.","volume":"59","author":"Rajasingham","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067311","article-title":"A prospective longitudinal study of the clinical outcomes from cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in Blantyre, Malawi.","volume":"8","author":"Rothe","year":"2013","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/cid\/ciu1137","article-title":"Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.","volume":"60","author":"Siedner","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062213","article-title":"Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program\u2013Vietnam.","volume":"8","author":"Smith","year":"2013","journal-title":"PLoS One"},{"key":"B31","author":"Sriruttan","year":"2016"},{"key":"B32","year":"2011","journal-title":"Rapid Advice: Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children"},{"key":"B33","year":"2016","journal-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00409\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T12:23:52Z","timestamp":1520943832000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00409\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":33,"alternative-id":["10.3389\/fmicb.2018.00409"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.00409","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,13]]},"article-number":"409"}}